drugset / Trial / NCT02301780
Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Phase III two arm double-blinded randomised controlled trial to examine the effect of prophylactic low-dose aspirin from the first-trimester of pregnancy in women at increased risk for PET on the incidence and severity of the disease
Timeline
- Start
- 2015-12
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 150 mg | — |